Evidence map›Paper›PMID 34540061›Full record

ArticleAmerican journal of translational research2021

The efficacy and safety of domestic and imported rapamycin drug-eluting stents and paclitaxel drug-coated balloons in the treatment of coronary bifurcation lesions.

Yue Dai, Ling Wang, Lingmin Fu, Jiehong Tu, Junhua Li, Yinghui Hu

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yue DaiNursing Department, Jiangxi Health Vocational College Nanchang, Jiangxi Province, China.
Ling WangNursing Department, Jiangxi Health Vocational College Nanchang, Jiangxi Province, China.
Lingmin FuNursing Department, Jiangxi Health Vocational College Nanchang, Jiangxi Province, China.
Jiehong TuDepartment of Cardiology, The Third Affiliated Hospital of Nanchang University Nanchang, Jiangxi Province, China.
Junhua LiDepartment of Cardiology, The Third Affiliated Hospital of Nanchang University Nanchang, Jiangxi Province, China.
Yinghui HuNursing Department, Jiangxi Health Vocational College Nanchang, Jiangxi Province, China.
Jiangxi Maternal and Child Health Hospital · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study was designed to analyze the efficacy and safety of domestic and imported rapamycin drug-eluting stents (DES) and paclitaxel drug-coated balloons (DCB) in the treatment of coronary bifurcation lesions.

methodsA total of 98 patients with coronary bifurcation lesions treated in our hospital from January 2019 to December 2019 were recruited as the study cohort and divided into four groups according to the different treatment method each patient underwent, including group A (n=25, treated with domestic rapamycin DES), group B (n=21, treated with imported rapamycin DES), group C (n=29, treated with domestic paclitaxel DCB), and group D (n=23, treated with imported paclitaxel DCB). The minimum lumen diameters (MLD), the diameter stenosis rates, the late lumen losses (LLLs), and the incidence of adverse events in each group were compared.

resultsThe MLD in the four groups were increased immediately after the surgeries and at nine months after the surgeries (

conclusionDomestic and imported rapamycin DES and paclitaxel DCB can effectively improve MLD, reduce the diameter stenosis rate, and have fewer adverse events in the treatment of coronary bifurcation lesions, and domestic and imported paclitaxel DCB have lower LLLs.

Indexed as

coronary bifurcation lesionsdrug-coated balloonsdrug-eluting stentspaclitaxelRapamycin

Identifiers

PMID34540061
PMCPMC8430079
OpenAlexW3199826915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.